[go: up one dir, main page]

NO20035399L - Pyrrolidinoksadiazol- og tiadiazolderivater - Google Patents

Pyrrolidinoksadiazol- og tiadiazolderivater

Info

Publication number
NO20035399L
NO20035399L NO20035399A NO20035399A NO20035399L NO 20035399 L NO20035399 L NO 20035399L NO 20035399 A NO20035399 A NO 20035399A NO 20035399 A NO20035399 A NO 20035399A NO 20035399 L NO20035399 L NO 20035399L
Authority
NO
Norway
Prior art keywords
thiadiazole derivatives
pyrrolidine oxadiazole
oxadiazole
pyrrolidine
thiadiazole
Prior art date
Application number
NO20035399A
Other languages
English (en)
Other versions
NO20035399D0 (no
Inventor
Matthias Schwarz
Russel J Thomas
Anna Quattorpani
Patrick Page
Vincent Pomel
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20035399D0 publication Critical patent/NO20035399D0/no
Publication of NO20035399L publication Critical patent/NO20035399L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20035399A 2001-06-18 2003-12-04 Pyrrolidinoksadiazol- og tiadiazolderivater NO20035399L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (2)

Publication Number Publication Date
NO20035399D0 NO20035399D0 (no) 2003-12-04
NO20035399L true NO20035399L (no) 2004-02-17

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035399A NO20035399L (no) 2001-06-18 2003-12-04 Pyrrolidinoksadiazol- og tiadiazolderivater

Country Status (26)

Country Link
US (2) US7115639B2 (no)
EP (1) EP1444225B1 (no)
JP (1) JP4426284B2 (no)
KR (1) KR20040030678A (no)
CN (1) CN100564378C (no)
AR (1) AR036108A1 (no)
AU (1) AU2002319237B2 (no)
BG (1) BG108424A (no)
BR (1) BR0211030A (no)
CA (1) CA2449578C (no)
CZ (1) CZ20033475A3 (no)
EA (1) EA006212B1 (no)
EE (1) EE200400022A (no)
ES (1) ES2397305T3 (no)
HR (1) HRP20031017A2 (no)
HU (1) HUP0400238A2 (no)
IL (1) IL159219A0 (no)
MX (1) MXPA03011441A (no)
MY (1) MY128890A (no)
NO (1) NO20035399L (no)
PL (1) PL367275A1 (no)
RS (1) RS99503A (no)
SK (1) SK15552003A3 (no)
UA (1) UA75145C2 (no)
WO (1) WO2002102799A2 (no)
ZA (1) ZA200309402B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2449578C (en) 2001-06-18 2011-12-13 Applied Research Systems Ars Holding N.V. Pyrrolidine oxadiazole- and thiadiazole derivatives
ATE449067T1 (de) 2003-02-27 2009-12-15 Merck Serono Sa Pyrrolidin-derivate als oxytocin antagonisten
EA011026B1 (ru) * 2004-02-26 2008-12-30 Лаборатуар Сероно Са Способ получения пирролидиноксимов
AU2006244068B9 (en) 2005-05-10 2012-10-25 Incyte Holdings Corporation Modulators of indoleamine 2,3-dioxygenase and methods of using the same
CA2634198C (en) 2005-12-20 2014-06-03 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
JP5319532B2 (ja) 2006-09-19 2013-10-16 インサイト・コーポレイション インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロサイクル
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
SG192485A1 (en) 2008-07-08 2013-08-30 Incyte Corp 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
SG11201603433UA (en) 2013-11-08 2016-05-30 Incyte Corp Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
UA122210C2 (uk) 2014-07-02 2020-10-12 Обсева С.А. Кристалічний о-метилоксим (3z,5s)-5-(гідроксиметил)-1-[(2'-метил-1,1'-біфеніл-4-іл)карбоніл]піролідин-3-oну, корисний у способах лікування станів, пов'язаних з активністю ot-r
TW202435864A (zh) 2023-02-09 2024-09-16 大陸商上海葆正醫藥科技有限公司 亞胺化合物及其製備方法和應用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
AU4763896A (en) 1995-01-24 1996-08-14 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
AU769652B2 (en) * 1999-05-05 2004-01-29 Cubist Pharmaceuticals, Inc. Novel prolines as antimicrobial agents
HRP20020705A2 (en) * 2000-03-27 2004-12-31 Applied Research Systems Pharmaceutically active pyrrolidine derivatives
PT1268418E (pt) * 2000-03-27 2006-08-31 Applied Research Systems Derivados da pirrolidina farmacologicamente activos com inibidores bax
WO2002032864A1 (en) * 2000-10-17 2002-04-25 Applied Research Systems Ars Holding N.V. Pharmaceutically active sulfanilide derivatives
DE60226431D1 (de) * 2001-03-20 2008-06-19 Serono Lab Pyrrolidinesterderivate mit oxytocinmodulierender wirkung
CA2449578C (en) 2001-06-18 2011-12-13 Applied Research Systems Ars Holding N.V. Pyrrolidine oxadiazole- and thiadiazole derivatives
IL162615A0 (en) * 2001-12-20 2005-11-20 Applied Research Systems Triazole derivatives, their preparation and pharmaceutical compositions containing them
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
IL159219A0 (en) 2004-06-01
PL367275A1 (en) 2005-02-21
EA006212B1 (ru) 2005-10-27
AU2002319237B2 (en) 2008-01-03
CN100564378C (zh) 2009-12-02
BG108424A (en) 2005-03-31
UA75145C2 (en) 2006-03-15
US7115639B2 (en) 2006-10-03
US20060229343A1 (en) 2006-10-12
EE200400022A (et) 2004-04-15
EP1444225A2 (en) 2004-08-11
RS99503A (sr) 2006-12-15
US20040220238A1 (en) 2004-11-04
MY128890A (en) 2007-02-28
CZ20033475A3 (en) 2004-05-12
WO2002102799A3 (en) 2003-04-03
SK15552003A3 (sk) 2004-05-04
WO2002102799A2 (en) 2002-12-27
JP2004534804A (ja) 2004-11-18
ES2397305T3 (es) 2013-03-06
EA200400049A1 (ru) 2004-08-26
HRP20031017A2 (en) 2004-04-30
ZA200309402B (en) 2004-12-03
AR036108A1 (es) 2004-08-11
HK1074204A1 (zh) 2005-11-04
HUP0400238A2 (hu) 2004-07-28
JP4426284B2 (ja) 2010-03-03
KR20040030678A (ko) 2004-04-09
EP1444225B1 (en) 2012-10-10
CA2449578A1 (en) 2002-12-27
CA2449578C (en) 2011-12-13
CN1639155A (zh) 2005-07-13
NO20035399D0 (no) 2003-12-04
BR0211030A (pt) 2004-06-22
MXPA03011441A (es) 2004-07-01

Similar Documents

Publication Publication Date Title
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
CY2016002I2 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
AR028343A1 (es) Derivados de pirrolidina y piperidina
ATE288437T1 (de) Tetrahydro-heterocycloazepinyl-pyrimidin-deriva e
IS6759A (is) Ný þíadíasól og oxadíasól og notkun þeirra sem fosfórdíesterasa-7 hindra
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE298332T1 (de) Decahydro-isochinolinderivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
ATE297920T1 (de) Linezolid-krystall form ii
DK1226131T3 (da) Isoxazolcarboxamidderivater
NO20035399D0 (no) Pyrrolidinoksadiazol- og tiadiazolderivater
EP1351388A4 (en) PHASE SLIDER AND MULTIBIT PHASE SLIDER
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
DE50113112D1 (de) Schaltungsanordnung
DE60004451D1 (de) Isothiazolonkonzentrate
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
ATE280752T1 (de) Aminomethyl-phenyl-cyclohexanonderivate
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
NO20023675D0 (no) Heterocykliske amidderivater
DE50003014D1 (de) N-substituierte perhydrodiazine